Safe Harbor and Non-GAAP Measures

Transcription

1

2 Safe Harbor and Non-GAAP Measures Forward-Looking Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of our future financial and operating performance and growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, the factors described in Risk Factors in VWR s Annual Report on Form 10- K, and its Quarterly Reports on Form 10-Q. Words such as "anticipates, "believes, "continues, "estimates, "expects, "goal, "objectives, "intends, "may, "opportunity, "plans, "potential, "near-term, "long-term, "projections, "assumptions, "projects, "guidance, "forecasts, "outlook, "target, "trends, "should, "could, "would, "will, and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data. Non-GAAP Measures To evaluate our performance, we monitor a number of key indicators at the consolidated level and, in certain cases, at the segment level. As appropriate, we supplement our results of operations determined in accordance with U.S. generally accepted accounting principles ( GAAP ) with certain non-gaap financial measurements that we believe are useful to investors, creditors and others in assessing our performance. These measurements should not be considered in isolation or as a substitute for reported GAAP results because they may include or exclude certain items as compared to similar GAAP-based measurements, and such measurements may not be comparable to similarly-titled measurements reported by other companies. Rather, these measurements should be considered as an additional way of viewing aspects of our operations that provide a more complete understanding of our business. We strongly encourage readers to review our consolidated financial statements in our publicly filed reports in their entirety and not rely solely on any one, single financial measurement. See Use of Non-GAAP Financial Measures in our press release issued today. 2

3 2Q15 Earnings Call Agenda Introduction John Sweeney VP, Investor Relations Overview Manuel Brocke-Benz President & CEO Financials & Outlook Greg Cowan SVP & CFO Business Highlights Manuel Brocke-Benz President & CEO Q&A 3

4 2Q15 Earnings Call Overview Manuel Brocke-Benz President & CEO 45

5 2Q15 Performance Summary Revenues ($B) Adjusted EPS $1.103 $1.081 $0.24 $0.34 2Q14 2Q15 2Q14 2Q15 2Q reported revenues $1.08B, down 1.9% YoY Strengthening of the U.S. dollar reduced revenues by 8.6% Organic revenue growth: Consolidated up 4.7%, Americas up 4.7% and EMEA-APAC up 4.7% Adjusted EBITDA $110.4M, up 4.8% YoY. Excluding currency and acquisitions, Adj. EBITDA increased by $10.9M or 10.4% Adjusted EPS grew 41.7% YoY to $

6 2Q15 EMEA-APAC Organic Improvement. Revenues ($M) Revenues declined 12.0% on a reported basis. Ongoing strengthening of the US$ reduced EMEA-APAC revenues by 17.9% YoY. $488 2Q14 $429 2Q15 2Q15 organic revenues increased 4.7% 1.3% contribution from acquisitions (17.9)% negative impact from currency OI ($M) $40 $36 Excluding currency and acquisitions, OI margin was 8.5%, up 40 bps compared to prior year Reported 2Q15 OI down 7.8% YoY Ex. currency & acquisitions, OI increased by $3.5M, or up 8.9% YoY 2Q14 2Q15 67

7 2Q15 EMEA-APAC: Continued Biopharma Growth Customer Segment Biopharma Healthcare Education Government Industrial Revenues by Product Consumables Chemicals Equip. & Instruments Growth +DD +MSD -LSD -MSD +LSD Growth +MSD +MSD +LSD 78

8 2Q15 Americas Solid Organic Growth Continues. Revenues ($M) $615 $652 Americas revenue growth driven by double-digit growth in Biopharma & continued strength in University customer revenues 2Q15 revenues up 6.0%, & up 4.7% organic 2.6% contribution from acquisitions (1.3)% impact from currency 2Q14 2Q15 OI ($M) Strong organic growth / leveraging Americas infrastructure drives 260 bps of OI margin expansion $23 2Q14 $41 2Q15 2Q15 OI increased 83% year-over-year Ex. currency, acquisitions, a 2Q14 impairment charge, and 2Q15 offering expenses of $0.9M, OI increased $6.0M, or up 17.8% 89

9 2Q15 Americas - Revenues Up 6.0% Customer Segment Biopharma Healthcare Education Government Industrial Revenues by Product Consumables Chemicals Equip. & Instruments Growth +DD +MSD +MSD +MSD -MSD Growth +LSD +DD +HSD 10 9

10 2Q15 Earnings Call - Financials & Outlook Greg Cowan SVP & CFO 11 10

11 2Q15 P&L (in millions, except EPS) 2Q15 2Q14 % chg. Net Sales $1,081.2 $1, % Cost of Goods Sold % Gross Profit % SG&A* % Operating Income % Net Interest (28.4) (44.9) -36.7% Other (19.2) 8.3 Pre-Tax Income Tax (11.7) (8.8) Net Income $18.3 $16.6 Non-GAAP Adjusted EPS $0.34 $ % * 2Q14 SG&A includes an $11.3M pre-tax CONFIDENTIAL impairment charge DRAFT related FOR to a DISCUSSION subsequently PURPOSES rescinded ONLY acquisition

12 Cash Flows ($ in millions) 2Q15 2Q14 % chg. 1H15 1H14 % chg. Cash From Operations $107.0 $ % $97.1 $ % Capital Expenditures (17.6)% % Free Cash Flow $100.0 $ % $80.6 $ % 13 12

13 2Q15 Deleveraging Continues. 9.3x Net Debt / LTM Adjusted EBITDA 8.4x 7.7x 7.1x 6.4x 6.9x 6.4x 4.4x 4.4x 4.3x Dec-07 Dec-08 Dec-09 Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 Mar-15 Jun

14 Reaffirmed FY15 Guidance ($ millions, except EPS) 2015 Guidance Range Low High Revenues $4,240 $4,310 Adjusted EBITDA $456 $463 Adjusted EPS $1.42 $1.50 Note: 2015 Adj. EPS guidance includes share-based compensation expense estimated at $5 to $6 million (pretax) Adj. EBITDA guidance excludes share-based compensation expense

15 2Q15 Earnings Call - Business Highlights Manuel Brocke-Benz President & CEO 16 15

16 VWR s Integrated IT Infrastructure A Sustainable Competitive Advantage. Globally Integrated IT Infrastructure One interface for each customer across all geographies Globally integrated web platform Continuous improvement Automating to increase service levels and enhance the customer experience 17 16

17 VWR Growth Story Remains On-Track Americas: 4.7% organic, 5 th positive data point EMEA-APAC accelerating growth, up 4.7% organic Leveraging our platform, providing differentiated services, and driving value for our customers Strengthening our balance sheet & deleveraging Executing a value creating acquisition strategy 2Q15 - another positive data point that indicates that the VWR growth story remains on-track 18 17

18 2Q15 Earnings Call Q&A 19 18

19 2Q15 Earnings Call Appendix 20 19

20 Non-GAAP Reconciliation (in millions, except per share amounts) Reconciliation of Adjusted Net Income FY13 1Q14 2Q14 3Q14 4Q14 FY14 1Q15 2Q15 Net income (loss) $ 14.1 $ 17.4 $ 16.6 $ 69.8 $ 48.8 $ $ 71.5 $ 18.3 Pre-tax adjustments: Amortization of acquired intangible assets Net foreign currency remeasurement (gain) loss from (8.2) (62.3) (23.4) (90.9) (70.3) 18.6 financing activities Restructuring and other cost reduction initiatives Legacy facility exit charges Impairment charges Gain on disposition of business (11.1) - (11.1) - - Loss on extinguishment of debt Charges associated with executive departures Parent secondary offering costs Other (0.2) Income tax (benefit) provision for pre-tax adjustments (57.3) (9.1) (9.1) (14.5) Adjusted Net Income* $ $ 36.4 $ 32.1 $ 34.6 $ 55.2 $ $ 43.8 $ 44.4 Adjusted EPS* $ 0.94 $ 0.28 $ 0.24 $ 0.26 $ 0.42 $ 1.20 $ 0.33 $ 0.34 Adjusted weighted average shares outstanding, diluted Reconciliation of Adjusted EBITDA FY13 1Q14 2Q14 3Q14 4Q14 FY14 1Q15 2Q15 Adjusted Net Income $ 36.4 $ 32.1 $ 34.6 $ $ 43.8 $ 44.4 Interest expense, net of interest income Depreciation expense Share-based compensation expense Income tax provision applicable to Adjusted Net Income Adjusted EBITDA $ $ $ $ $ $ $ $ Adjusted EBITDA Margin 10.0% 10.6% 9.5% 10.1% 10.8% 10.3% 10.4% 10.2% * Adjusted Net Income and Adjusted EPS include share-based compensation expense

21 Non-GAAP Reconciliation (dollars in millions) Reconciliation of Net Debt and Net Leverage FY13 1Q14 2Q14 3Q14 4Q14 FY14 1Q15 2Q15 Debt and capital lease obligations $ 2,854.4 $ 2,860.2 $ 2,844.6 $ 2,739.0 $ 2,111.9 $ 2,111.9 $ 2,063.3 $ 2,066.5 Less: Cash and cash equivalents (135.6) (130.2) (151.6) (120.8) (118.0) (118.0) (98.5) (129.9) Compensating cash balance (25.9) (16.5) (17.0) (13.9) (2.5) (2.5) (0.2) - Net Debt $ 2,692.9 $ 2,713.5 $ 2,676.0 $ 2,604.3 $ 1,991.4 $ 1,991.4 $ 1,964.6 $ 1,936.6 LTM Adjusted EBITDA Net Leverage 6.4x 6.3x 6.0x 5.8x 4.4x 4.4x 4.4x 4.3x Reconciliation of Free Cash Flow FY13 1Q14 2Q14 3Q14 4Q14 FY14 1Q15 2Q15 Cash flow from operations $ $ 15.2 $ 53.3 $ 18.7 $ $ $ (9.9) $ Less: Capital expenditures (45.3) (6.6) (8.5) (8.2) (10.3) (33.6) (9.5) (7.0) Free Cash Flow $ $ 8.6 $ 44.8 $ 10.5 $ 93.6 $ $ (19.4) $

22 VWR Investor Contact John Sweeney, CFA VP Investor Relations Phone: (610)